Triazolines 34. Structure and Stability Relationships of Novel Δ2-1,2,3-Triazoline Anticonvulsants

Pharmaceutical Research

Volumn 13, Issue 1, 1996, Pages 179-182

  Chow, Albert H L ^a   Chiu, Francis C K ^a   Damani, L A ^a   Kadaba, Pankaja K ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b University of Kentucky   (United States)

Author keywords

Chemical stability; Degradation kinetics; Novel triazoline anticonvulsants; Structure stability relationships

Indexed keywords

ANTICONVULSIVE AGENT; TRIAZOLINE DERIVATIVE;

ARTICLE; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG STABILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; PRIORITY JOURNAL;

ANTICONVULSANTS; BIODEGRADATION, ENVIRONMENTAL; DRUG STABILITY; HALF-LIFE; HYDROGEN-ION CONCENTRATION; KINETICS; MOLECULAR STRUCTURE; TRIAZOLES;

EID: 0029867718     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016018409546     Document Type: Article

References (11)

1. 2-1,2,3-Triazolines as a new class of anticonvulsants. J. Pharm. Sci. 73:850-852 (1984).
2. Kadaba, P. K. Triazolines 14. 1,2,3-Triazolines and triazoles, a new class of anticonvulsants. Drug design and structure activity relationships. J. Med. Chem. 31:196-203 (1988).
3. Kadaba, P. K. and Slevin, J. T. Triazolines 15. Anticonvulsant profile of ADD17014, a potentially unique 1,2,3-triazoline antiepileptic drug in mice and rats. Epilepsia. 29:330-337 (1988).
4. Kadaba, P. K. 1,2,3-Triazolines: a new generation of anticonvulsant agents effective in the kindling model of epilepsy, with a unique mechanism for impairing excitatory amino acid neurotransmission. Drugs of the Future. 15:1013-1024 (1990).
5. Hamelijnck, M. A. F., Stevenson, P. J., Kadaba, P. K. and Damani, L. A. Triazolines. XXI. Preformulation degradation kinetics and chemical stability of a novel triazoline anticonvulsant. J. Pharm. Sci. 81:392-396 (1992).
6. 2-1,2,3-triazoline, Ph.D. thesis, University of London, 1994, pp. 169-178.
7. Scheiner, P. Triazoline decomposition. In Thyagarajan, B. S. (ed). Selective Organic Transformations. Vol. I, Wiley-Interscience, New York, 1970, pp. 328-362.
8. 2-1,2,3-Triazolines. Adv. Heterocycl. Chem. 37:217-349 (1984).
9. Deshmukh, T. R. and Kadaba, P. K. Triazolines 28. Identification of the triazoline pharmacophore and the evolution of the aminoalkylpyridines, a new class of potent orally active anticonvulsant agents. Med. Chem. Res. 3:223-232 (1993).
10. 2-1,2,3-Triazoline anticonvulsants: novel 'built in' heterocyclic prodrugs with a unique 'dual-action' mechanism for impairing excitatory amino acid L-glutamate neurotransmission. Bioorg. Med. Chem. (Accepted).
11. Kubinyi, H. The quantitative analysis of structure-activity relationships. In Wolff, M. E. (ed). Burger's Medicinal Chemistry and Drug Discovery. Vol. I: Principles and Practice. 5th Ed., John Wiley and Sons, New York, 1995, pp. 497-571.